Clare Arnold
About Clare Arnold
Clare Arnold serves as the Head of QC UK&I at MeiraGTx, a position she has held since 2021. Her extensive experience includes roles at Lonza, Orchard Therapeutics, GlaxoSmithKline, and Boehringer Ingelheim, spanning over two decades in quality control and assurance.
Current Role at MeiraGTx
Clare Arnold serves as the Head of QC UK&I at MeiraGTx, a position she has held since 2021. In this role, she oversees quality control operations within the UK and Ireland, ensuring compliance with industry standards and regulations. Her leadership contributes to the company's commitment to delivering high-quality gene therapies.
Previous Experience at Lonza
Clare Arnold has extensive experience at Lonza, where she held multiple roles. She worked as the QC Biochemistry Section Leader from 2011 to 2013, followed by positions as QC Projects Manager from 2013 to 2016 and Head of QC Chemistry from 2016 to 2018. Additionally, she served as QA Manager from 2018 to 2020. Her tenure at Lonza spanned nearly a decade, providing her with a solid foundation in quality control and assurance.
Experience at Orchard Therapeutics
Clare Arnold worked at Orchard Therapeutics as a Senior Quality Assurance Manager from 2020 to 2021. During her time in this role, she focused on maintaining high standards of quality assurance within the organization, contributing to the development and delivery of innovative therapies.
Background at GlaxoSmithKline and Boehringer Ingelheim
Clare Arnold began her career at GlaxoSmithKline, where she worked in various roles from 2002 to 2008 for six years. She then transitioned to Boehringer Ingelheim, serving as Team Leader of Analytical Services from 2008 to 2010. These positions provided her with diverse experience in the pharmaceutical industry, enhancing her expertise in quality control and assurance.